Company developing early cancer-detection tests to cut 20% of workforce

The 10-year-old company — part of a group of Bay Area companies that have raised billions of dollars over the past decade — recently netted $254 million to develop tests that can sniff out various cancers from a simple blood draw or “liquid biopsy.”
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks